The main campus of the Center for Disease Control and Prevention (CDC) in Atlanta, Georgia, U.S., August 27, 2025. REUTERS/Alyssa Pointer
FILE PHOTO: Dr. Kirk Milhoan speaks to Dr. James Pagano during an Advisory Committee on Immunization Practices (ACIP) meeting at the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, U.S., September 19, 2025. REUTERS/Alyssa Pointer/File Photo

Dec 4 (Reuters) - A group of vaccine advisers to the U.S. Centers for Disease Control and Prevention will vote on whether to delay the initial dose of hepatitis B vaccine to 2 months of age for the vast majority of American children, a fresh agenda posted on the agency's website showed on Wednesday.

(Reporting by Mariam Sunny in Bengaluru; Editing by Shailesh Kuber)